Expertise in
15
conditions
Expertise in
15
conditions
Brewer-Northern Light Cancer Care
33 Whiting Hill Rd, 
Brewer, ME 

Overview

Nadine Santacruz is a Hematologist and an Oncologist in Brewer, Maine. Dr. Santacruz is highly rated in 15 conditions, according to our data. Her top areas of expertise are Hepatoblastoma, Langerhans Cell Histiocytosis, Intersex, Denys-Drash Syndrome (DDS), and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 2 peer reviewed articles and participating in 52 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology
Oncology

Licenses

Pediatric Hematology-Oncology in NH

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cigna
  • EPO
  • HMO
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
NH Healthy Families
  • EPO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 3 Less Insurance Carriers -

Locations

Brewer-Northern Light Cancer Care
33 Whiting Hill Rd, Brewer, ME 04412
Other Locations
Brewer-Northern Light Pediatric Cancer Care
33 Whiting Hill Rd Ste 31, Brewer, ME 04412

Additional Areas of Focus

Dr. Santacruz has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)
Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


52 Clinical Trials

Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Neuroblastoma Biology Studies
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Renal Tumors Classification, Biology, and Banking Study
Key Adverse Events After Childhood Cancer
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
View 41 Less Clinical Trials
Similar Doctors
Expertise in
15
conditions
Hematology
Expertise in
15
conditions
Hematology

Brewer-Northern Light Cancer Care

33 Whiting Hill Rd, 
Brewer, ME 
 (191.0 miles away)
Experience:
17+ years
Languages Spoken:
English
Offers Telehealth

Kamal Sahu is a Hematologist in Brewer, Maine. Dr. Sahu has been practicing medicine for over 17 years is highly rated in 15 conditions, according to our data. His top areas of expertise are Methemoglobinemia, Thrombocytopenia, Plasmacytoma, Splenectomy, and Gastrostomy.

Expertise in
36
conditions
Expertise in
36
conditions

Office

33 Whiting Hill Rd Ste 21, 
Brewer, ME 
 (191.1 miles away)
Languages Spoken:
English
Offers Telehealth

Sarah Sinclair is a Hematologist in Brewer, Maine. Dr. Sinclair is highly rated in 36 conditions, according to our data. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Bone Marrow Aspiration.

Expertise in
23
conditions
Expertise in
23
conditions

Office

33 Whiting Hill Rd Ste 21, 
Brewer, ME 
 (191.1 miles away)
Languages Spoken:
English

Audrey Garrett is an Oncologist in Brewer, Maine. Dr. Garrett is highly rated in 23 conditions, according to our data. Her top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Breast Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration.

Frequently Asked Questions about Dr. Nadine Santacruz

How do I make an appointment with Dr. Nadine Santacruz?

You can book an appointment with Dr. Nadine Santacruz by calling their office at 207-973-7478. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Nadine Santacruz a top-rated expert for Hepatoblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Nadine Santacruz is classified as an Advanced expert for Hepatoblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Nadine Santacruz specialize in?

While Dr. Nadine Santacruz is a Hematology, they have specific expertise in Hepatoblastoma, Langerhans Cell Histiocytosis, and Intersex. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Nadine Santacruz participate in research or clinical trials?

Yes. Dr. Nadine Santacruz has published 2 articles and abstracts on conditions like Hepatoblastoma. You can view a list of Dr. Nadine Santacruz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Nadine Santacruz accept my insurance?

Dr. Nadine Santacruz accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 207-973-7478 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Santacruz's expertise for a condition
ConditionClose
      View All 15 Advanced Conditions
      View All 19 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile